JPWO2019179345A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019179345A5 JPWO2019179345A5 JP2020551267A JP2020551267A JPWO2019179345A5 JP WO2019179345 A5 JPWO2019179345 A5 JP WO2019179345A5 JP 2020551267 A JP2020551267 A JP 2020551267A JP 2020551267 A JP2020551267 A JP 2020551267A JP WO2019179345 A5 JPWO2019179345 A5 JP WO2019179345A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- gene
- recombinant virus
- ehv
- fmdv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018079410 | 2018-03-19 | ||
| CNPCT/CN2018/079410 | 2018-03-19 | ||
| PCT/CN2019/078057 WO2019179345A1 (en) | 2018-03-19 | 2019-03-14 | Recombinant virus capable of stably expressing target proteins |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021518152A JP2021518152A (ja) | 2021-08-02 |
| JPWO2019179345A5 true JPWO2019179345A5 (https=) | 2022-03-17 |
| JP2021518152A5 JP2021518152A5 (https=) | 2022-03-17 |
| JP7387623B2 JP7387623B2 (ja) | 2023-11-28 |
Family
ID=67988104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551267A Active JP7387623B2 (ja) | 2018-03-19 | 2019-03-14 | 標的タンパク質を安定して発現できる組換えウイルス |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11904010B2 (https=) |
| EP (1) | EP3768831A4 (https=) |
| JP (1) | JP7387623B2 (https=) |
| KR (1) | KR102785418B1 (https=) |
| CN (1) | CN111902535B (https=) |
| AU (1) | AU2019237413C1 (https=) |
| CA (1) | CA3094416A1 (https=) |
| MX (1) | MX2020009720A (https=) |
| WO (1) | WO2019179345A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3094416A1 (en) * | 2018-03-19 | 2019-09-26 | Boehringer Ingelheim Vetmedica (China) Co., Ltd. | Recombinant virus capable of stably expressing target proteins |
| CA3162622A1 (en) * | 2019-11-25 | 2021-06-03 | Baylor College Of Medicine | Selective expansion of gene-targeted cells |
| CN112430625B (zh) * | 2020-11-23 | 2022-08-05 | 武汉枢密脑科学技术有限公司 | 含有变异猪伪狂犬病病毒gD蛋白基因的重组腺相关病毒转移载体、病毒及其制备和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4110962A1 (de) * | 1991-04-05 | 1992-10-08 | Bayer Ag | Equine herpesviren (ehv), die fremd-dna enthalten, verfahren zu ihrer herstellung und ihre verwendung in impfstoffen |
| MX9206981A (es) * | 1991-12-06 | 1994-08-31 | Whitehead Biomedical Inst | Vacunas de recombinantes y metodo para producirlas. |
| GB9927353D0 (en) * | 1999-11-19 | 2000-01-19 | Cantab Pharma Res | Virus preparation and use |
| EP2468768A3 (en) * | 2005-07-21 | 2012-10-31 | Abbott Laboratories | Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis |
| BRPI0618441B8 (pt) * | 2005-11-10 | 2021-07-27 | Genvec Inc | vetor adenoviral |
| CN101444622A (zh) * | 2008-06-06 | 2009-06-03 | 中国人民解放军军事医学科学院军事兽医研究所 | 以猪伪狂犬病病毒为载体的日本血吸虫基因重组活疫苗生产工艺及制品 |
| RU2546247C2 (ru) | 2013-06-06 | 2015-04-10 | Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") | Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак |
| MA42640B1 (fr) * | 2015-11-23 | 2021-06-30 | Merial Inc | Protéines de fusion de dmdv et e2 et leurs utilisations |
| CN107723281B (zh) | 2017-09-09 | 2021-02-12 | 中国农业科学院哈尔滨兽医研究所 | 表达猪圆环病毒2型Cap蛋白的重组猪瘟兔化弱毒疫苗株及其应用 |
| EA202092164A1 (ru) * | 2018-03-19 | 2021-02-10 | Бёрингер Ингельхайм Ветмедика Гмбх | Новый ehv с инактивированным ul18 и/или ul8 |
| CA3094416A1 (en) * | 2018-03-19 | 2019-09-26 | Boehringer Ingelheim Vetmedica (China) Co., Ltd. | Recombinant virus capable of stably expressing target proteins |
-
2019
- 2019-03-14 CA CA3094416A patent/CA3094416A1/en active Pending
- 2019-03-14 AU AU2019237413A patent/AU2019237413C1/en active Active
- 2019-03-14 CN CN201980019886.5A patent/CN111902535B/zh active Active
- 2019-03-14 EP EP19770578.3A patent/EP3768831A4/en active Pending
- 2019-03-14 US US17/046,210 patent/US11904010B2/en active Active
- 2019-03-14 WO PCT/CN2019/078057 patent/WO2019179345A1/en not_active Ceased
- 2019-03-14 JP JP2020551267A patent/JP7387623B2/ja active Active
- 2019-03-14 MX MX2020009720A patent/MX2020009720A/es unknown
- 2019-03-14 KR KR1020207029714A patent/KR102785418B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10799578B2 (en) | Vaccine against porcine parvovirus | |
| CN113666990B (zh) | 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用 | |
| CN1440296B (zh) | 抗口蹄疫疫苗 | |
| US10905756B2 (en) | Bivalent swine influenza virus vaccine | |
| JP7587612B2 (ja) | 改変ｐｅｄｖスパイクタンパク質 | |
| JP2001514871A (ja) | 組換えブタ・アデノウイルス・ベクター | |
| TW201823465A (zh) | 新穎豬流感疫苗 | |
| JP2022527627A (ja) | ３型ブタサーコウイルス（ｐｃｖ３）ワクチン、ならびにその作製および使用 | |
| CA3181812A1 (en) | African swine fever vaccine composition | |
| US20210338807A1 (en) | Covid19 vaccines and related methods | |
| CN105695491A (zh) | 鸡新城疫糖蛋白病毒抗原的制备方法及其产品 | |
| JP2021518152A5 (https=) | ||
| JP7387623B2 (ja) | 標的タンパク質を安定して発現できる組換えウイルス | |
| JPWO2019179345A5 (https=) | ||
| CN120714018B (zh) | 一种用于获得牛结节性皮肤病病毒中和抗体的mRNA疫苗及其应用 | |
| RU2854013C1 (ru) | Вакцина против алеутской болезни норок | |
| IL176634A (en) | Monoparamunity inducers based on attenuated rabbit myxoma viruses | |
| RU2816428C2 (ru) | Рекомбинантный вирус, способный к устойчивой экспрессии белков-мишеней | |
| RU2816428C9 (ru) | Рекомбинантный вирус, способный к устойчивой экспрессии белков-мишеней | |
| KR101484305B1 (ko) | Ｈ3 말 인플루엔자 ａ 바이러스 | |
| EA045363B1 (ru) | Вакцина против свиного парвовируса |